Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2025-12-25 @ 4:36 AM
NCT ID:
NCT01892618
Eligibility Criteria:
Inclusion Criteria:
* Untreated CLL patients all Rai stages (0 to IV), as early as possible after diagnosis, always before any therapy with monoclonal antibodies and/or chemotherapy
Exclusion Criteria:
* Immunosuppressive therapy planned to start within 1 month
* Other malignancies
* Corticosteroids or other immunosuppressive drugs
* Previous allergic reaction to any vaccination in the past
* Neutropenia (PMNs \< 500 cells/mm3)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT01892618
Study Brief:
Protocol Section:
NCT01892618